Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab

Ben JACOBS, Ali JAWAD, Zozik FATTAH

Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom

Keywords: Intestinal perforation; pneumatosis intestinalis; tocilizumab

Abstract

In this article, we report a case of pneumatosis intestinalis associated with tocilizumab use. This is a unique case and may explain the increased rate of idiopathic bowel perforation among patients taking tocilizumab.

Citation: Jacobs B, Jawad A, Fattah Z. Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Arch Rheumatol 2018;33(3):372-375.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.